Arionkoder, the AI consulting firm, will be at ViVE 2026, Feb. 22–25 in Los Angeles, to discuss business demands and ...

In this video, Camilla W. Kilbane, MD, discusses how to approach monitoring patients after they initiate treatment for tardive dyskinesia.

Science is a subject built on doing. Students learn chemistry through titrations, biology through dissections, physics ...

Tanmay Bhat has hit a roadblock with his GLP-1 medication. The comedian shared that he is experiencing zero appetite ...

Losing weight with the help of a prescription weight loss drug continues to increase in popularity. According to recent KFF polls, about one in eight U.S. adults takes a GLP-1 medication for ...

Neuroscience reveals why some people perform brilliantly under pressure but unravel when life is calm — and how a threat-adapted nervous system can learn to tolerate safety.

An informational overview of Ivím Health's compounded semaglutide and tirzepatide telehealth program, including GLP-1 ID cost breakdown, weekly provider check-in structure, clinical claims analysis, a ...

Insmed Incorporated (NASDAQ:INSM) Q4 2025 Earnings Call Transcript February 19, 2026 Insmed Incorporated misses on earnings ...

To bridge the gap between clinical exuberance and evidence-based practice, Todd Brown, MD, PhD, an endocrinologist and clinical investigator at Johns Hopkins University, sat down at the Conference on ...

At this time, I would like to welcome everyone to Harmony Biosciences' Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] Please be advised that today's ...

Vanda Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTItm (milsaperidone) tablets, a first line therapy for the acute treatment of manic or ...

You won’t need to Ferberize yourself. Not exactly.